Colorectal Carcinoma
|
|
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
THYROID CANCER, NONMEDULLARY, 2
|
|
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
melanoma
|
|
0.720 |
GeneticVariation
|
BEFREE |
Melanomas had p.V600E (n = 30), p.V600K (n = 4), p.K601E (n = 1), p.600-601delinsE (n = 1), or no p.V600 mutations (n = 31).
|
23651150 |
2014 |
Splenic Marginal Zone B-Cell Lymphoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
A BRAF K601E mutation was detected in a patient with splenic marginal zone lymphoma.
|
22133769 |
2012 |
Follicular adenoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
A distinct mutation in BRAF (codon K600E) was detected in a follicular adenoma.
|
12881714 |
2003 |
Thyroid Gland Follicular Adenoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
A distinct mutation in BRAF (codon K600E) was detected in a follicular adenoma.
|
12881714 |
2003 |
Papillary thyroid carcinoma
|
|
0.070 |
GeneticVariation
|
BEFREE |
A distinct mutation in BRAF (codon K600E) was detected in three cases of the follicular variant of PTC.
|
14743508 |
2004 |
Neoplasms
|
|
0.780 |
GeneticVariation
|
BEFREE |
All cases positive for the BRAF(K601E) mutation were reviewed to confirm histopathologic diagnosis and establish tumor variant, and clinical charts were reviewed to obtain clinical characteristics and follow-up information.
|
26422023 |
2016 |
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
|
17060676 |
2006 |
Follicular Variant Thyroid Gland Papillary Carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
BRAF V600E/K601E and RAS mutational analysis was performed on 187 FVPTCs.
|
25648502 |
2015 |
melanoma
|
|
0.720 |
GeneticVariation
|
CLINVAR |
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.
|
22972589 |
2013 |
Neoplasms
|
|
0.780 |
GeneticVariation
|
BEFREE |
Cytology was consistent with "follicular neoplasia" (negative for galectin-3 immunostaining); molecular analysis on the cytology sample detected a K601E mutation in the exon 15 of the BRAF gene.
|
22136270 |
2011 |
melanoma
|
|
0.720 |
GeneticVariation
|
CLINVAR |
Determinants of BRAF mutations in primary melanomas.
|
14679157 |
2003 |
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
|
23012255 |
2012 |
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.
|
24455489 |
2014 |
Secondary Neoplasm
|
|
0.020 |
GeneticVariation
|
BEFREE |
Further studies are necessary to clarify the putative clinical significance (e.g. association to blood-born metastases) of PAX8-PPARgamma rearrangement, RAS mutations, and BRAF(K601E) in FVPTCs.
|
16219715 |
2006 |
Neoplasm Metastasis
|
|
0.020 |
GeneticVariation
|
BEFREE |
Further studies are necessary to clarify the putative clinical significance (e.g. association to blood-born metastases) of PAX8-PPARgamma rearrangement, RAS mutations, and BRAF(K601E) in FVPTCs.
|
16219715 |
2006 |
Follicular Variant Thyroid Gland Papillary Carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Further studies are necessary to clarify the putative clinical significance (e.g. association to blood-born metastases) of PAX8-PPARgamma rearrangement, RAS mutations, and BRAF(K601E) in FVPTCs.
|
16219715 |
2006 |
Cardio-facio-cutaneous syndrome
|
|
0.800 |
CausalMutation
|
CLINVAR |
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
19206169 |
2009 |
Cardio-facio-cutaneous syndrome
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
19206169 |
2009 |
Noonan Syndrome
|
|
0.700 |
CausalMutation
|
CLINVAR |
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
|
19206169 |
2009 |
Cardio-facio-cutaneous syndrome
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.
|
23263490 |
2013 |
Cardio-facio-cutaneous syndrome
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.
|
16439621 |
2006 |
Colorectal Carcinoma
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
|
22855150 |
2012 |